microRNA-877 contributes to decreased non-small cell lung cancer cell growth via the PI3K/AKT pathway by targeting tartrate resistant acid phosphatase 5 activity

References

• Santos FN, De Castria TB, Cruz MR, et al. Chemotherapy for advanced non-small cell lung cancer in the elderly population. Cochrane Database Syst Rev. 2015;10:CD010463.
   Google Scholar
• Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012;307(22):2418–2429. .
   PubMed Web of Science ®Google Scholar
• Mulherkar R, Grewal AS, Berman AT. Emerging role of immunotherapy in locally advanced non-small cell lung cancer. Clin Adv Hematol Oncol. 2020;18(4):212–217.
   PubMed Web of Science ®Google Scholar
• Reck M, Popat S, Reinmuth N, et al. Metastatic non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(Suppl 3):iii27–39. .
   PubMed Web of Science ®Google Scholar
• Fajersztajn L, Veras M, Barrozo LV, et al. Air pollution: a potentially modifiable risk factor for lung cancer. Nat Rev Cancer. 2013;13(9):674–678. .
   PubMed Web of Science ®Google Scholar
• Torres-Duran M, Fernandez-Villar A, Barros-Dios JM, et al. Residential radon: the neglected risk factor in lung cancer risk scores. J Thorac Oncol. 2016;11(9):1384–1386. .
   PubMed Web of Science ®Google Scholar
• Zarogoulidis P, Baka S, Labaki S, et al. Targeted lung cancer treatments and eye metastasis. Med Hypothesis Discov Innov Ophthalmol. 2017;6(1):10–13.
   PubMedGoogle Scholar
• Yao Z, Fenoglio S, Gao DC, et al. TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer. Proc Natl Acad Sci U S A. 2010;107(35):15535–15540. .
   PubMed Web of Science ®Google Scholar
• Shen J, Liao J, Guarnera MA, et al. Analysis of MicroRNAs in sputum to improve computed tomography for lung cancer diagnosis. J Thorac Oncol. 2014;9(1):33–40. .
   PubMed Web of Science ®Google Scholar
• Shi Q, Xu X, Liu Q, et al. MicroRNA-877 acts as a tumor suppressor by directly targeting eEF2K in renal cell carcinoma. Oncol Lett. 2016;11(2):1474–1480. .
   PubMed Web of Science ®Google Scholar
• Wang C, Gu S, Cao H, et al. miR-877-3p targets Smad7 and is associated with myofibroblast differentiation and bleomycin-induced lung fibrosis. Sci Rep. 2016;6(30122).
   Google Scholar
• Halling Linder C, Ek-Rylander B, Krumpel M, et al. Bone alkaline phosphatase and tartrate-resistant acid phosphatase: potential co-regulators of bone mineralization. Calcif Tissue Int. 2017;101(1):92–101. .
   PubMed Web of Science ®Google Scholar
• Gao YL, Liu MR, Yang SX, et al. Prognostic significance of ACP5 expression in patients with lung adenocarcinoma. Clin Respir J. 2018;12(3):1100–1105. .
   PubMed Web of Science ®Google Scholar
• Chen M, Du Y, Qui M, et al. Ophiopogonin B-induced autophagy in non-small cell lung cancer cells via inhibition of the PI3K/Akt signaling pathway. Oncol Rep. 2013;29(2):430–436.
   PubMed Web of Science ®Google Scholar
• Ji Y, Han Z, Shao L, et al. Evaluation of in vivo antitumor effects of low-frequency ultrasound-mediated miRNA-133a microbubble delivery in breast cancer. Cancer Med. 2016;5(9):2534–2543. .
   PubMed Web of Science ®Google Scholar
• Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Adv Exp Med Biol. 2016;893(1–19).
   PubMedGoogle Scholar
• Li C, Lyu J, Meng QH. MiR-93 promotes tumorigenesis and metastasis of non-small cell lung cancer cells by activating the PI3K/Akt pathway via inhibition of LKB1/PTEN/CDKN1A. J Cancer. 2017;8(5):870–879.
   PubMed Web of Science ®Google Scholar
• Ke Y, Zhao W, Xiong J, et al. miR-149 inhibits non-small-cell lung cancer cells EMT by targeting FOXM1. Biochem Res Int. 2013;2013:506731.
   PubMedGoogle Scholar
• Luo W, Huang B, Li Z, et al. MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met. PLoS One. 2013;8(5):e64759. .
   PubMed Web of Science ®Google Scholar
• Huang X, Qin J, Lu S. Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1. Int J Clin Exp Pathol. 2015;8(2):1515–1524.
   PubMed Web of Science ®Google Scholar
• Othman N, In LL, Harikrishna JA, et al. Bcl-xL silencing induces alterations in hsa-miR-608 expression and subsequent cell death in A549 and SK-LU1 human lung adenocarcinoma cells. PLoS One. 2013;8(12):e81735. .
   PubMed Web of Science ®Google Scholar
• Xu P, Cai X, Zhang W, et al. Flavonoids of Rosa roxburghii Tratt exhibit radioprotection and anti-apoptosis properties via the Bcl-2(Ca(2+))/Caspase-3/PARP-1 pathway. Apoptosis. 2016;21(10):1125–1143. .
   PubMed Web of Science ®Google Scholar
• Cui R, Kim T, Fassan M, et al. MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7. Oncotarget. 2015;6(26):21802–21815. .
   PubMedGoogle Scholar
• You J, Zhang Y, Liu B, et al. MicroRNA-449a inhibits cell growth in lung cancer and regulates long noncoding RNA nuclear enriched abundant transcript 1. Indian J Cancer. 2014;51(Suppl 3):e77–81. .
   PubMedGoogle Scholar
• Yamashita N, Tokunaga E, Iimori M, et al. Epithelial Paradox: clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer. Clin Breast Cancer. 2018;18(5):e1003–e1009. .
   PubMed Web of Science ®Google Scholar
• Myong NH. Loss of E-cadherin and acquisition of vimentin in epithelial-mesenchymal transition are noble indicators of uterine cervix cancer progression. Korean J Pathol. 2012;46(4):341–348.
   PubMedGoogle Scholar
• Yuan X, Wu H, Han N, et al. Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application. J Hematol Oncol. 2014;7:87.
   PubMed Web of Science ®Google Scholar
• Jia Z, Zhang Y, Xu Q, et al. miR-126 suppresses epithelial-to-mesenchymal transition and metastasis by targeting PI3K/AKT/Snail signaling of lung cancer cells. Oncol Lett. 2018;15(5):7369–7375.
   PubMed Web of Science ®Google Scholar
• Wang X, Qiu H, Tang R, et al. miR30a inhibits epithelialmesenchymal transition and metastasis in triplenegative breast cancer by targeting ROR1. Oncol Rep. 2018;39(6):2635–2643.
   PubMed Web of Science ®Google Scholar
• Qu J, Li M, An J, et al. MicroRNA-33b inhibits lung adenocarcinoma cell growth, invasion, and epithelial-mesenchymal transition by suppressing Wnt/beta-catenin/ZEB1 signaling. Int J Oncol. 2015;47(6):2141–2152.
   PubMed Web of Science ®Google Scholar
• Guerriero I, D’angelo D, Pallante P, et al. Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells. Oncotarget. 2017;8(12):19172–19191.
   PubMedGoogle Scholar